Osimertib

osimertinib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Osimertib, covering 2024-02-28 to 2024-02-28. Get the full timeline:

Most recent: Clinical Trial Update: MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib [Phase 2]